First-trimester screening for trisomies by cfDNA testing of maternal blood in singleton and twin pregnancies: factors affecting test failure

被引:59
|
作者
Galeva, S. [1 ,2 ]
Gil, M. M. [1 ,3 ,4 ]
Konstantinidou, L. [1 ]
Akolekar, R. [2 ,5 ]
Nicolaides, K. H. [1 ]
机构
[1] Kings Coll Hosp London, Fetal Med Res Inst, 16-20 Windsor Walk,Denmark Hill, London SE5 8BB, England
[2] Medway Maritime Hosp, Dept Fetal Med, Gillingham, Kent, England
[3] Univ Francisco Vitoria, Sch Hlth Sci, Madrid, Spain
[4] Hosp Univ Torrejon, Obstet & Gynecol Dept, Madrid, Spain
[5] Canterbury Christ Church Univ, Inst Med Sci, Chatham, Kent, England
关键词
cell-free DNA; fetal fraction; first-trimester screening; non-invasive prenatal testing; trisomy; 13; 18; 21; twin pregnancy; CELL-FREE DNA; WEEKS GESTATION RELATION; 1ST TRIMESTER; DOWN-SYNDROME; FETAL; IMPLEMENTATION; ANEUPLOIDIES; IMPACT;
D O I
10.1002/uog.20290
中图分类号
O42 [声学];
学科分类号
070206 ; 082403 ;
摘要
Objective To examine factors affecting the rate of failure to obtain a result from cell-free DNA (cfDNA) testing of maternal blood for fetal trisomies 21, 18 and 13 in singleton and twin pregnancies in the first trimester. Methods This was a prospective study of 23 495 singleton and 928 twin pregnancies undergoing screening for fetal trisomy by targeted cfDNA testing at 10+0 to 14+1 weeks' gestation. Multivariate logistic regression analysis was used to determine significant predictors of failure to obtain a result after first sampling. Results There was no result from cfDNA testing after first sampling in 3.4% (798/23 495) of singletons, 11.3% (91/806) of dichorionic twins and 4.9% (6/122) of monochorionic twins. Multivariate logistic regression analysis demonstrated that the risk of test failure, first, increased with increasing maternal age (odds ratio (OR), 1.02; 95% CI, 1.01-1.04) and weight (OR, 1.05; 95% CI, 1.04-1.05), decreasing gestational age (OR, 0.85; 95% CI, 0.79-0.91), serum pregnancy-associated plasma protein-A (PAPP-A) multiples of the median (MoM) (OR, 0.56; 95% CI, 0.49-0.65) and free beta-human chorionic gonadotropin (beta-hCG) MoM (OR, 0.67; 95% CI, 0.60-0.74), second, was higher in women of black (OR, 1.72; 95% CI, 1.33-2.20) and South Asian (OR, 1.99; 95% CI, 1.56-2.52) than those of white racial origin, in dichorionic twin than in singleton pregnancy (OR, 1.75; 95% CI, 1.34-2.26) and in pregnancies conceived by in-vitro fertilization than in those conceived naturally (OR, 3.82; 95% CI, 3.19-4.55) and, third, was lower in parous than in nulliparous women (OR, 0.63; 95% CI, 0.55-0.74). Conclusions Maternal age, weight, racial origin and parity, gestational age, dichorionicity, method of conception and serum levels of free beta-hCG and PAPP-A are independent predictors of cfDNA test failure. The risk of test failure is higher in dichorionic twin than in singleton pregnancies, mainly because a higher proportion of twins are conceived by in-vitro fertilization and more of the women are nulliparous. Copyright (c) 2019 ISUOG. Published by John Wiley & Sons Ltd.
引用
收藏
页码:804 / 809
页数:6
相关论文
共 38 条
  • [1] Prospective first-trimester screening for trisomies by cell-free DNA testing of maternal blood in twin pregnancy
    Sarno, L.
    Revello, R.
    Hanson, E.
    Akolekar, R.
    Nicolaides, K. H.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2016, 47 (06) : 705 - 711
  • [2] First-trimester screening for trisomies in pregnancies with vanishing twin
    Chaveeva, P.
    Wright, A.
    Syngelaki, A.
    Konstantinidou, L.
    Wright, D.
    Nicolaides, K. H.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2020, 55 (03) : 326 - 331
  • [3] Screening for trisomies by cfDNA testing of maternal blood in twin pregnancy: update of The Fetal Medicine Foundation results and meta-analysis
    Gil, M. M.
    Galeva, S.
    Jani, J.
    Konstantinidou, L.
    Akolekar, R.
    Plana, M. N.
    Nicolaides, K. H.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2019, 53 (06) : 734 - 742
  • [4] Routine first-trimester screening for fetal trisomies in twin pregnancy: cell-free DNA test contingent on results from combined test
    Galeva, S.
    Konstantinidou, L.
    Gil, M. M.
    Akolekar, R.
    Nicolaides, K. H.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2019, 53 (02) : 208 - 213
  • [5] Screening for Common Fetal Trisomies in Twin Pregnancies: First-Trimester Combined, Cell-Free DNA, or Both?
    Pasquini, Lucia
    Ponziani, Ilaria
    Periti, Enrico
    Marchi, Laura
    Luchi, Carlo
    Accurti, Veronica
    D'Ambrosi, Francesco
    Persico, Nicola
    FETAL DIAGNOSIS AND THERAPY, 2019, 46 (04) : 217 - 222
  • [6] First-trimester contingent screening for trisomies 21, 18 and 13 by fetal nuchal translucency and ductus venosus flow and maternal blood cell-free DNA testing
    Kagan, K. O.
    Wright, D.
    Nicolaides, K. H.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2015, 45 (01) : 42 - 47
  • [7] First-Trimester Screening for Gestational Diabetes Mellitus in Twin Pregnancies
    Buerger, Olga
    Elger, Tania
    Varthaliti, Antonia
    Syngelaki, Argyro
    Wright, Alan
    Nicolaides, Kypros H.
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (17)
  • [8] First-trimester screening for trisomy 21 in singleton pregnancies achieved by assisted reproduction
    Liao, AW
    Heath, V
    Kametas, N
    Spencer, K
    Nicolaides, KH
    HUMAN REPRODUCTION, 2001, 16 (07) : 1501 - 1504
  • [9] First-trimester screening for Down syndrome in singleton pregnancies achieved by intrauterine insemination
    Lai, TH
    Chen, SC
    Tsai, MS
    Lee, FK
    Wei, CF
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2003, 20 (08) : 327 - 331
  • [10] First-Trimester Screening for Down Syndrome in Singleton Pregnancies Achieved by Intrauterine Insemination
    Tsung-Hsuan Lai
    Su-Chee Chen
    Ming-Song Tsai
    Fa-Kung Lee
    Chi-Feng Wei
    Journal of Assisted Reproduction and Genetics, 2003, 20 : 327 - 331